BHS Medical Solutions GmbH Schnaiter Str. 11 73630 Remshalden, Germany

Tanda Distt. Kangra PIN-176001, H.P. India

  • Email : info@bhs-medical.com

The pandemic situation caused by SARS-CoV-2 is threatening human health and public safety worldwide. This respiratory virus is causing the acute respiratory disease COVID-19 and has spread all over the world. Infection caused by SARS-CoV-2 infection vary from an asymptomatic course to mild symptoms to severe respiratory failure. Thus, the main symptoms of COVID-19 are fever, dry coughs and fatigue. Severe cases, in particularly in children or older patients, can range up to respiratory failure and death. As the virus is transmitted by aerosols, many precautions have been taken in different countries. One major step in combating the pandemic are the different vaccines, but curative treatments are not available. Besides oxygen therapy, corticosteroids and anti-thrombotic medicines, there are no proven effective therapies for COVID-19 or antivirals against SARS-CoV-2.

The SARS-CoV-2 pandemic has disrupted the Indian country with 0.4 million cases and thousands of deaths in the second infection wave. Although, the vaccines reduced the number of cases and deaths, the virus mutations are increasing worldwide.

BHS Medical Solution is grateful that AgSept® has been approved to be used as drug in treatment of severe COVID-19 patients in an investor-initiated study with 40 patients. In this clinical trial, successful results were gained. We will be glad to keep you updated on those great news, please contact us for more information.“

BHS Medical Solutions © 2021 - 2022. All rights reserved. Impressum